Abstract
The aim of this study was to evaluate the histopathological changes in a model of New Zealand white rabbits after the ocular instillation of a fixed combination containing 0.09 % xanthan gum and 0.1 % chondroitin sulfate for 15 days. This was a preclinical study which compared the previously described combination with placebo on an animal model of sixteen New Zealand white rabbits. The intervention consisted of the instillation of one drop of a fixed combination containing 0.09 % xanthan gum and 0.1 % chondroitin sulfate on the right eye of each rabbit 6 times per day (every 2 h) in a 12-hour period for 15 days. The left eyes were used as control. Assessments on the anterior and posterior segment, ocular signs, and specific ocular surface characteristics were conducted at days 0, 1, 2, 4, 7, 10, and 15. Histopathological studies of the corneal and conjunctival epithelium were performed at the end of the intervention. No significant changes were observed during the assessments of the anterior and posterior segments. No differences in the number of goblet cells between groups were reported. The histopathological study of the corneal basement membrane’s thickness, stromal, and conjunctival epithelium did not show significant changes between groups. The use of a fixed-dose combination containing 0.09 % xanthan gum and 0.1 % chondroitin sulfate on the ocular surface of New Zealand white rabbits every 2 h for 15 days causes no histopathological changes in anterior/posterior segments, nor a decrease in the number of goblet cells compared with placebo.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Tiffany J (2008) The normal tear film. Dev Ophthalmol 41:1–20
Stahl U, Wilcox M, Stapleton F (2012) Osmolality and tear film dynamics. Clin Exp Optom 95:3–11
Montés-Micó R (2007) Role of the tear film in the optical quality of the human eye. J Cataract Refract Surg 33:1631–1635
Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC (1998) The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 17:584–589
Török M, Süveges I (1982) Morphological changes in dry eye syndrome. Graefes Arch Clin Exp Opthalmol 219:24–28
Kunet KS, Tisdale AS, Gipson IK (2002) Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. Arch Opthalmol 120:330–337
Alves M et al (2013) Dry eye disease treatment: a systematic review of published trials and a critical appraisal of therapeutic strategies. Ocul Surf 11:185–192
Liesegang TJ (2013) Viscoelastic substances in ophthalmology. Ocul Surf 11:185–192
Nepp J et al (2001) The clinical use of viscoelastic artificial tears and sodium chloride in dry eye syndrome. Biomaterials 22:3305–3310
Hammer ME, Burch TG (1984) Viscous corneal protection by sodium hyaluronate chondroitin sulfate, and methylcellulose. Investig Ophthalmol Vis Sci 25:1329–1332
Petri DFS (2015) Xanthan gum: a versatile biopolymer for medical and technological applications. J Appl Polym Sci 132:42035
Bhowmik M, Kumari P, Sarkar G et al (2013) Effect of xanthan gum and guar gum on in situ gelling ophthalmic drug delivery system based on poloxamer-407. Int J Biol Macromol 62:117–123
De Paiva CS, Villarreal AL, Corrales RM et al (2007) Dry Eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-γ. Investig Ophthalmol Vis Sci 48:2553–2560
Moshirfar M, Pierson K, Hanamaikai K et al (2014) Artificial tears potpourri: a literature review. Clin Ophthalmol 8:1419–1433
Rahman MQ, Chuah K-S, Macdonald ECA, Trusler JPM, Ramesh K (2012) The effect of pH, dilution, and temperature on the viscosity of ocular lubricants-shift in rheological parameters and potential clinical significance. Eye 26:1579–1584
Limberg MB et al (1987) Topical application of hyaluronate acid and chondroitin sulfate in the treatment of dry eyes. Am J Ophthalmol 103:194–197
Stadler J, Stefanovic-Racic M, Billiar TR et al (1991) Articular chondrocytes synthetize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol 147:3915–3920
Amico C, Tornetta T, Scifo C, Blanco AR (2014) Antioxidant effect of 0.2 % xanthan gum in ocular surface corneal epithelial cells. Curr Eye Res, pp 1–5
Faraldi F, Papa V, Santoro D et al (2012) A new eye gel containing sodium hyaluronate and xanthan gum for the management of post-traumatic corneal abrasions. Clin Ophthalmol 6:727–731
Moon JW, Lee HJ, Shin KC et al (2007) Short term effects of topical cyclosporine and viscoelastic on the ocular surfaces in patients with dry eye. Kor J Ophthalmol 21:189–194
Pflugfelder SC, Tseng SC, Yoshino K et al (1997) Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose Bengal staining in patients with ocular irritation. Ophthalmology 104:223–235
Ceulemans J, Vinckier I, Ludwig A (2002) The use of xanthan gum in an ophthalmic liquid dosage form: rheological characterization of the interaction with mucin. J Pharm Sci 91(4):1117–1127
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Contreras-Rubio, A.Y., Baiza-Durán, L., Olvera-Montaño, O. et al. Histopathological changes on the ocular surface of New Zealand white rabbits after instillation of a fixed combination of 0.09 % xanthan gum and 0.1 % chondroitin sulfate. Int Ophthalmol 36, 841–844 (2016). https://doi.org/10.1007/s10792-016-0192-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-016-0192-9